業 績 一 覧 2024

原著

1. Bandoh N, Goto T, Kato Y, Kubota A, Sakaue S, Takeda R, Hayashi S, Hayashi M, Baba S, Yamaguchi-Isochi T, Nishihara H, Kamada H. BRAF V600E mutation co-existing with oncogenic mutations is associated with aggressive clinicopathologic features and poor prognosis in papillary thyroid carcinoma. Asian J Surg. 2024 Jan;47(1):413-419.
2. Sunami K, Naito Y, Saigusa Y, Amano T, Ennishi D, Imai M, Kage H, Kanai M, Kenmotsu H, Komine K, Koyama T, Maeda T, Morita S, Sakai D, Hirata M, Ito M, Kozuki T, Sakashita H, Horinouchi H, Okuma Y, Takashima A, Kubo T, Hironaka S, Segawa Y, Yakushijin Y, Bando H, Makiyama A, Suzuki T, Kinoshita I, Kohsaka S, Ohe Y, Ishioka C, Yamamoto K, Tsuchihara K, Yoshino T. A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence. JAMA Oncol. 2024 Jan 1;10(1):95-102.
3. Kage H, Akiyama N, Chang H, Shinozaki-Ushiku A, Ka M, Kawata J, Muto M, Okuma Y, Okita N, Tsuchihara K, Kikuchi J, Shirota H, Hayashi H, Kokuryo T, Yachida S, Hirasawa A, Kubo M, Kenmotsu H, Tanabe M, Ushiku T, Muto K, Seto Y, Oda K. Patient survey on cancer genomic medicine in Japan under the national health insurance system. Cancer Sci. 2024 Mar;115(3):954-962.
4. Shimoi T, Sunami K, Tahara M, Nishiwaki S, Tanaka S, Baba E, Kanai M, Kinoshita I, Shirota H, Hayashi H, Nishida N, Kubo T, Mamesaya N, Ando Y, Okita N, Shibata T, Nakamura K, Yamamoto N. Dabrafenib and trametinib administration in patients with BRAF V600E/R or non-V600 BRAF mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trial. EClinicalMedicine. 2024 Feb 2:69:102447.
5. Nakamura K, Hayashi H, Kawano R, Ishikawa M, Aimono E, Mizuno T, Kuroda H, Kojima Y, Niikura N, Kawanishi A, Takeshita K, Suzuki S, Ueno S, Okuwaki K, Sasaki J, Yamaguchi M, Masuda K, Chiyoda T, Yamagami W, Okada C, Nohara S, Tanishima S, Nishihara H. BRCA1/2 reversion mutations in a pan-cancer cohort. Cancer Sci. 2024 Feb;115(2):635-647.
6. Saito A, Terai H, Kim TJ, Emoto K, Kawano R, Nakamura K, Hayashi H, Takaoka H, Ogata A, Kinoshita K, Ito F, Shigematsu L, Okada M, Fukushima T, Mitsuishi A, Shinozaki T, Ohgino K, Ikemura S, Yasuda H, Kawada I, Soejima K, Nishihara H, Fukunaga K. Clinical utility of the Oncomine Dx Target Test multi-CDx system and the possibility of utilizing those original sequence data. Cancer Med. 2024 Feb;13(4):e7077.
7. Nakano Y, Shimane G, Nakamura K, Takamatsu R, Aimono E, Yagi H, Abe Y, Hasegawa Y, Hori S, Tanaka M, Masugi Y, Kitago M, Nishihara H, Kitagawa Y. Next-generation sequencing to identify genetic mutations in pancreatic cancer using intraoperative peritoneal washing fluid. Oncol Lett. 2024 Feb 2;27(4):139.
8. Honda S, Yamaguchi H, Aimono E, Hara S, Minamiguchi S, Norose T, Ohike N, Yamochi T, Yasuda M, Moriya T, Shiko Y, Nishihara H, Nagao T. High-grade Solid Pseudopapillary Neoplasms of the Pancreas: Distinct Clinicopathological Malignant Features With Intriguing Gene Alterations through a Comparison With the Conventional Type. Am J Surg Pathol. 2024 Mar 1;48(3):353-363.
9. Mizutani K, Sugiyama S, Kameyama K, Kamei S, Yokoi S, Morikawa A, Takeuchi M, Seike K, Yamada T, Ehara H, Sawada S, Hirade K, Furuta H, Matsunaga K, Yamada T, Sakamoto I, Kato Y, Nishihara H, Ishihara S, Deguchi T. Impact of Tumor Grade Distribution on Genetic Alterations in Clear Cell Renal Cell Carcinoma and Prostate Cancer. Cancer Genomics Proteomics. 2024 Mar-Apr;21(2):203-212.
10. Kakumoto A, Jamiyan T, Kuroda H, Harada O, Yamaguchi-Isochi T, Baba S, Kato Y, Nishihara H, Kawami H. Prognostic impact of tumor-associated neutrophils in breast cancer. Int J Clin Exp Pathol. 2024 Mar 15;17(3)51-62.
11. Ishikawa M, Nakamura K, Kawano R, Hayashi H, Ikeda T, Saito M, Niida Y, Sasaki J, Okuda H, Ishihara S, Yamaguchi M, Shimada H, Isobe T, Yuza Y, Yoshimura A, Kuroda H, Yukisawa S, Aoki T, Takeshita K, Ueno S, Nakazawa J, Sunakawa Y, Nohara S, Okada C, Nishimiya K, Tanishima S, Nishihara H. Clinical and Diagnostic Utility of Genomic Profiling for Digestive Cancers: Real-World Evidence from Japan. Cancers (Basel). 2024 Apr 15;16(8):1504.
12. Nakamura K, Hoshi H, Kobayashi M, Fukasawa K, Ichikawa S, Shigihara Y. Dorsal brain activity reflects the severity of menopausal symptoms. Menopause. 2024 May 1;31(5):399-407.
13. Matsuda S, Hoshino S, Goto T, Kawakubo H, Takeuchi M, Kobayashi R, Nakamura K, Takeuchi H, Nishihara H, Kitagawa Y. Identifying intense inflammatory subtype of esophageal squamous cell carcinoma using clustering approach. Gen Thorac Cardiovasc Surg. 2024 Jun; 72(6):417-425.
14. Kaneko Y, Masuda T, Takamatsu K, Mikami S, Nakamura K, Nishihara H, Mizuno R, Tanaka N, Oya M. Volumetric imaging of the tumor microvasculature effects outcomes and genomic state of clear cell renal cell carcinoma. J Pathol Clin Res. 2024 Jul;10(4):e12388.
15. Hsu CY, Yanagi T, Maeda T, Nishihara H, Funakoshi T, Miyamoto K, Iwamoto R, Takahashi K, Ujiie H. Establishment of a trastuzumab-resistant extramammary Paget disease model: loss of PTEN as a potential mechanism. Br J Cancer. 2024 Jul 10.
16. Nakamura K, Ishikawa M, Kawano R, Aimono E, Mizuno T, Nohara S, Tanishima S, Hayashi H, Nishihara H; Keio PleSSision Group. Characterizing multi-PIK3CA mutations across cancer types: Toward precision oncology. Cancer Med. 2024 Jul;13(14):e70052.
17. Shimane G, Nakano Y, Matsuda S, Kitago M, Masugi Y, Nakamura K, Nakamura Y, Yagi H, Abe Y, Hasegawa Y, Hori S, Tanaka M, Takemura R, Nishihara H, Kitagawa Y. Molecular diagnosis for detecting KRAS mutation in peritoneal washing fluid of pancreatic ductal adenocarcinoma. Sci Rep. 2024 Sep 17;14(1):21732.
18. Chida A, Kawasaki K, Kuramoto J, Hayashi H, Kawahara T, Makiuchi S, So E, Shimizu S, Kishimoto S, Horie S, Saito Y, Shimozaki K, Tsugaru K, Togasaki K, Hirata K, Nishihara H, Kanai Y, Kanai T, Hamamoto Y. Clinical characteristics of gastrointestinal stromal tumors with hypoglycemia. Oncol Lett. 2024 Sep 26;28(6):568.
19. Takamatsu R, Nakamura K, Chiyoda T, Tsuji K, Kawano R, Yoshimi N, Yamagami W, Nishihara H. Advancing Precision Oncology: Whole-Exome Sequencing in Endometrial Cancer Liquid-Based Cytology. Arch Pathol Lab Med. 2024 Oct 14. Online ahead of print.

症例報告

1. Hayashi H, Kunimasa K, Tanishima S, Nakamura K, Ishikawa M, Kato Y, Aimono E, Kawano R, Nishihara H. Germline BRCA2 variant with low variant allele frequency detected in tumor-only comprehensive genomic profiling. Cancer Sci. 2024 Feb;115(2):682-686.
2. Hayashi S, Bandoh N, Hayashi M, Goto T, Kato Y, Baba S, Aimono E, Nishihara H. Salivary Salivary Duct Carcinoma Arising in the Submandibular Gland in a Patient with Neurofibromatosis Type 1. Ear Nose Throat J. 2024 Online head of print.
3. Tokuchi K, Yanagi T, Kurosawa S, Kitamura S, Maeda T, Hsu CY, Miyamoto K, Nishihara H, Ujiie H. Clinical-histopathological features and cancer gene analysis of cutaneous epithelioid angiosarcoma: A report of 4 cases. JAAD Case Rep. 2024 Feb 10:46:45-48.
4. Hayashi S, Bandoh N, Baba S, Hayashi M, Goto T, Takahara M, Kato Y, Aimono E, Nishihara H. A case of hyalinizing trabecular tumor of the thyroid: diagnostic significance of PAX8-GLIS3 fusion. Thyroid Res. 2024 May 6;17(1):9.
5. Takano N, Takamura M, Mizuno Y, Mizuno Y, Tamaru S, Nakamura K, Soma H, Kajihara T. Genetic and histological analysis intraplacental choriocarcinoma: a case report. Med Mol Morphol. 2024 Jun;57(2):147-154.
6. Zaitsu S, Aoyagi Y, Nishida H, Nakamura K, Yano M, Kobayashi E. Genetic profiling of sebaceous carcinoma arising from an ovarian mature teratoma: A case report. Int J Mol Sci. 2024 Jun 8;25(12):6351.
7. Kameyama K, Mizutani K, Yamada T, Sugiyama S, Kamei S, Yokoi S, Matsunaga K, Hirade K, Kato Y, Nishihara H, Ishihara S, Deguchi T. Genomic analysis of bladder urothelial carcinoma with osteoclast-like giant cells: A case report. Mol Clin Oncol. 2024 Jun 20;21(2):55.
8. Kobayashi Y, Nakamura Y, Tahara U, Nakamura K, Nakanishi K, Miyagawa A, Horikawa H, Kobayashi K, Funakoshi T, Sugano K, Ushiama M, Yoshida T, Inazumi T. Identification of a rare MET variant in a familial case of extramammary Paget’s disease. Clin Exp Dermatol. 2024 Jul 19;49(8):882-886.
9. Hanaoka T, Okuwaki K, Nakamura K, Okada S, Nishizawa N, Watanabe M, Iwai T, Adachi K, Kumamoto Y, Kusano C. High likelihood of BRCA2 reversion mutation in pancreatic cancer post-platinum-based chemotherapy: a case study. Int Cancer Conf J. 2024 Aug 16;13(4):493-498.
10. Ito K, Nakamura K, Kajihara T, Shinozaki Y, Imura J, Sakuma H. Coexistence of complete intestinal tract, prostatic tissue, prostatic urethra and bladder structure in ovarian mature cystic teratoma: a case report. Med Mol Morphol. 2024 Nov;11. Online ahead of print.